Cytosurge AG
Selina Schmid is an experienced human resources professional currently serving as HR Manager and HR Business Partner at Cytosurge AG since April 2021. Prior to this role, Selina held the position of Personalbereichsleiterin at Stadler from March 2020 to March 2021 and worked in a travel-related role for a company focused on South America and Asia from November 2018 to February 2020. Previous experience also includes roles as a Human Resources Generalist and Human Resources Assistant at SoftwareONE from July 2015 to October 2018 and as a Team Assistant at job impuls ag from September 2012 to August 2014. Selina's educational background includes a degree in HR Fachfrau mit eidg. Fachausweis from GET Kaderschule (2017-2018), a degree as Personalassistentin from AKAD (2015-2016), and the Cambridge Certificate of Proficiency in English (C2) from SELC Sydney (2014-2015).
Cytosurge AG
Cytosurge AG, founded in 2009, is a biotechnology company that manufactures and distributes cutting-edge solutions based on its patented FluidFM® technology. At the heart of this technology are the hollow FluidFM Probes – the Micropipette, Nanopipette, and the Nanosyringe – specifically designed to offer a wide range of unique applications for single-cell manipulation in biology research. Cytosurge's current systems compatible with FluidFM probes include the FluidFM ADD-ON for AFM systems and the standalone semi-automated FluidFM OMNIUM system. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, contributing to human well-being through advancements in single-cell technologies. As the partner of choice for precision gene engineering cell line manufacturing, Cytosurge enables next-generation biologic production and cell and gene therapy treatments, empowering people to live longer and healthier lives. Cytosurge implements advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and the manufacturing of high-precision gene-engineered cell lines. With a unique single-cell workflow and dynamic gene expression analytics, Cytosurge manufactures advanced gene-engineered cell lines, empowering next-generation treatments to benefit human well-being.